Key takeaways
- CKM syndrome does not have one specific symptom pattern because it involves several interconnected metabolic, kidney, and cardiovascular conditions.
- Prediabetes, high blood pressure, early chronic kidney disease, and even some cardiovascular abnormalities can exist without noticeable symptoms.
- Symptoms such as swelling, shortness of breath, palpitations, fatigue, or leg pain may appear as particular CKM-related conditions become more advanced.
- Chest pain, possible stroke symptoms, or severe breathing difficulty require urgent medical attention rather than self-assessment for CKM syndrome.
- Testing and risk assessment are more reliable than symptoms for identifying CKM syndrome before advanced disease develops.
Cardiovascular-kidney-metabolic (CKM) syndrome does not have one distinctive set of symptoms. That is one of the most important things to understand about it. CKM syndrome is a framework that brings together metabolic risk factors, chronic kidney disease, cardiovascular risk, and cardiovascular disease, and many of those problems can develop for years without producing obvious symptoms.
The 2026 American Heart Association CKM framework describes Stage 1 as early metabolic change, Stage 2 as metabolic risk factors and/or chronic kidney disease, and Stage 3 as subclinical cardiovascular disease or very high cardiovascular or kidney risk. The AHA specifically characterizes Stage 3 as a period of “silent damage” because cardiovascular changes may already be detectable even when the person does not feel sick.
Symptoms become more likely when CKM-related conditions become more advanced, but even then they depend on which organs and diseases are involved. Shortness of breath may point toward a heart problem, swelling may occur with heart or kidney disease, and leg pain with walking can occur with peripheral artery disease—but none of these symptoms by itself establishes a CKM diagnosis or stage.
Does CKM Syndrome Cause Symptoms?
CKM syndrome itself is not a disease with a single symptom checklist in the way that an infection might cause a predictable combination of fever, sore throat, and cough.
Instead, CKM describes the interconnected relationship among metabolic abnormalities, chronic kidney disease, and cardiovascular disease. The symptoms a person develops depend on which components are present, how advanced they are, and whether organ damage has begun.
This distinction is especially important because the early stages of CKM are often identified through measurements and laboratory tests rather than through physical symptoms.
The AHA’s current patient guidance notes that many CKM-related health conditions begin silently. Stage 3 can be identified through testing or imaging that finds heart, kidney, or blood-vessel abnormalities even when a person has no symptoms.
That means feeling healthy does not necessarily establish that blood pressure, blood glucose, kidney function, or cardiovascular risk is normal.
Why Early CKM Syndrome Can Be Silent
Several of the conditions that help define early and intermediate CKM stages are well known for causing few or no symptoms.
Prediabetes Often Has No Clear Symptoms
Prediabetes is part of the Stage 1 CKM framework. Blood glucose is higher than normal but has not reached the diagnostic range for diabetes.
The Centers for Disease Control and Prevention notes that a person can have prediabetes for years without clear symptoms. Because someone may feel completely well, blood glucose testing rather than symptoms is usually what reveals the problem.
This is one reason increased thirst, frequent urination, or other symptoms commonly associated with more pronounced hyperglycemia should not be treated as prerequisites for metabolic risk. CKM changes may already be present before symptoms emerge.
High Blood Pressure Usually Does Not Announce Itself
Hypertension is one of the major conditions included in Stage 2 CKM syndrome.
For most people, high blood pressure causes no obvious symptoms. The American Heart Association emphasizes that blood pressure must be measured to determine whether it is high rather than inferred from headaches, dizziness, or how someone feels.
This matters because persistent hypertension can affect blood vessels, the heart, kidneys, brain, and other organs even when the person feels normal.
Early Chronic Kidney Disease Can Also Be Symptom-Free
Chronic kidney disease (CKD) is another major component of Stage 2 CKM syndrome, and very-high-risk CKD can contribute to Stage 3 classification.
According to the National Institute of Diabetes and Digestive and Kidney Diseases, most people with early CKD have no symptoms, and some do not develop noticeable symptoms until kidney disease is advanced. Blood and urine testing may therefore be the only way to identify early kidney dysfunction.
This is particularly important for people with diabetes, hypertension, cardiovascular disease, or other reasons to be at increased kidney risk.
Subclinical Cardiovascular Disease Is Silent by Definition
Stage 3 CKM syndrome can involve subclinical cardiovascular disease.
“Subclinical” means disease or organ changes are present but have not yet produced the symptoms or clinical events that would normally bring the condition to attention. The AHA’s 2026 staging material describes this stage as silent damage and includes subclinical atherosclerotic cardiovascular disease and subclinical heart failure.
A person may therefore reach a relatively advanced CKM risk category before experiencing chest pain, noticeable shortness of breath, or another obvious cardiovascular symptom.
How Symptoms May Change Across CKM Stages
The CKM stages are based on clinical findings and risk rather than symptoms, so symptoms do not map perfectly onto individual stages. Still, the staging system helps explain why symptoms generally become more likely as disease becomes more advanced.
| CKM stage | What is happening | Are symptoms expected? |
|---|---|---|
| Stage 0 | No identified CKM risk factors | No CKM-related symptoms are expected |
| Stage 1 | Excess or dysfunctional adiposity and/or prediabetes | Often no symptoms |
| Stage 2 | Metabolic risk factors and/or CKD | Frequently still silent; symptoms depend on the condition |
| Stage 3 | Subclinical cardiovascular disease, very-high-risk CKD, or very high predicted cardiovascular risk | May have no symptoms despite clinically important risk or organ changes |
| Stage 4 | Established cardiovascular disease, sometimes with kidney failure | Symptoms are more likely but vary by the specific cardiovascular and kidney conditions |
Stage 4 can include coronary heart disease, heart failure, stroke, peripheral artery disease, and atrial fibrillation. The AHA patient toolkit notes that people at this stage may experience symptoms such as chest pain, shortness of breath, weakness, leg pain, swelling, or slow wound healing.
However, even established cardiovascular disease is not guaranteed to produce obvious symptoms at all times. For example, some people with atrial fibrillation or peripheral artery disease have few or no noticeable symptoms.
Possible Symptoms as Kidney Disease Becomes More Advanced
When CKD becomes more advanced, symptoms may begin to reflect the kidneys’ reduced ability to remove waste, regulate fluid, and maintain normal physiological balance.
Possible symptoms include:
- Swelling in the legs, feet, or ankles
- Fatigue
- Sleep problems
- Loss of appetite
- Nausea or vomiting
- Muscle cramps
- Itching
- Difficulty concentrating
- Changes in urination
- Foamy urine
- Shortness of breath
NIDDK emphasizes that these symptoms are more common as kidney disease becomes advanced and that early CKD usually causes no symptoms.
Kidney failure can produce more substantial fluid retention, weakness, nausea, poor appetite, itching, difficulty concentrating, changes in urine production, and other symptoms. These symptoms are not specific to kidney failure, however, and many have other possible causes.
Cardiovascular Symptoms That Can Appear in Advanced CKM
Stage 4 CKM syndrome includes established cardiovascular disease. The symptoms depend on the particular cardiovascular condition present.
Shortness of Breath, Swelling, and Reduced Exercise Tolerance
Heart failure can cause shortness of breath during activity or at rest, swelling in the legs or abdomen, fatigue, persistent coughing or wheezing, and difficulty performing activities that previously felt manageable.
Fluid accumulation may also cause relatively rapid changes in body weight.
Some of these symptoms overlap with advanced kidney disease. That illustrates one of the challenges of CKM syndrome: symptoms do not necessarily identify which organ system is responsible because heart and kidney dysfunction can produce similar manifestations.
Palpitations or an Irregular Heartbeat
Atrial fibrillation, one of the cardiovascular conditions included in Stage 4 CKM, may cause:
- A fluttering or pounding sensation in the chest
- A rapid or irregular heartbeat
- Fatigue
- Weakness
- Dizziness or lightheadedness
- Shortness of breath
- Reduced exercise tolerance
Some people with atrial fibrillation experience no symptoms at all and learn that they have the condition during an examination or cardiac testing.
Palpitations can have many causes besides atrial fibrillation, so the sensation alone cannot identify the rhythm abnormality.
Leg Pain During Walking
Peripheral artery disease (PAD) occurs when narrowed or blocked arteries reduce blood flow, most commonly to the legs.
One characteristic symptom is aching, cramping, burning, heaviness, or fatigue in a leg during walking or other activity that improves with rest. Some people may also develop slowly healing sores, cooler skin on one foot or leg, or changes in skin color.
But PAD can also be silent. The AHA notes that many people with PAD do not have symptoms or mistakenly attribute leg discomfort to arthritis, aging, or another musculoskeletal problem.
Symptoms Do Not Tell You Your CKM Stage
It may be tempting to assume that no symptoms means Stage 0 or Stage 1 and severe symptoms mean Stage 4. CKM staging does not work that way.
Someone with Stage 2 hypertension and CKD may feel completely healthy. Someone in Stage 3 can have cardiovascular changes detectable through imaging or other testing without symptoms. Conversely, fatigue, swelling, dizziness, or shortness of breath can occur for many reasons unrelated to CKM syndrome.
Determining CKM stage may involve information such as:
- Blood pressure
- BMI and waist circumference
- Blood glucose or HbA1c
- Triglycerides and other blood lipids
- Estimated glomerular filtration rate (eGFR)
- Urine albumin-to-creatinine ratio (UACR)
- Medical history
- PREVENT cardiovascular risk estimation
- Selected cardiovascular testing or imaging when appropriate
That is why symptoms are not a substitute for clinical assessment.
For a fuller explanation of how these measurements are used, see our guide to CKM syndrome screening and tests.
When Should Someone Discuss Possible CKM Risk With a Healthcare Professional?
You do not need to wait for symptoms before discussing CKM health.
A conversation may be particularly useful for people who already know they have one or more CKM-related conditions, including:
- Prediabetes
- Type 2 diabetes
- Hypertension
- High triglycerides
- Obesity or increased abdominal adiposity
- Metabolic syndrome
- Chronic kidney disease
- Coronary heart disease
- Heart failure
- Atrial fibrillation
- Peripheral artery disease
- A previous stroke
The 2026 CKM guideline recommends staging and risk assessment to help identify people at risk of progression and guide prevention and treatment. It also recommends using PREVENT cardiovascular risk estimation in appropriate people in Stages 0 through 3.
New or persistent symptoms such as unexplained swelling, recurring palpitations, reduced exercise tolerance, persistent leg pain with walking, or unexplained shortness of breath also warrant medical evaluation even though they are not specific to CKM syndrome.
Warning Signs That Need Urgent Medical Attention
CKM syndrome itself is generally assessed through routine or planned medical care. Certain symptoms associated with cardiovascular emergencies are different: they require prompt action rather than waiting for a CKM evaluation.
Possible Heart Attack
The American Heart Association advises calling 911 for possible heart attack symptoms. Warning signs may include:
- Chest pressure, squeezing, fullness, or pain
- Discomfort in one or both arms, the back, neck, jaw, or stomach
- Shortness of breath, with or without chest discomfort
- Cold sweating
- Nausea
- Lightheadedness
- Unusual or sudden severe fatigue
Heart attacks do not always begin with dramatic chest pain. Some start gradually with relatively mild discomfort.
Possible Stroke
Stroke symptoms require immediate emergency evaluation. The American Stroke Association uses the B.E. F.A.S.T. approach: sudden balance problems, vision changes, facial drooping, arm weakness, or speech difficulty are reasons to call 911 immediately.
Symptoms that disappear after a few minutes still require urgent evaluation because a transient episode may represent a transient ischemic attack or another serious problem.
Severely Elevated Blood Pressure With Concerning Symptoms
High blood pressure normally causes no symptoms. However, the AHA advises that a blood pressure above 180/120 mm Hg accompanied by symptoms such as chest pain, shortness of breath, weakness, numbness, vision changes, back pain, or difficulty speaking can represent a hypertensive emergency and requires immediate emergency care.
A very high reading without those symptoms also needs timely medical attention, but it is handled differently from a hypertensive emergency.
Why Relying on Symptoms Can Delay CKM Detection
Many people naturally seek medical attention when something hurts or feels wrong. That approach is less reliable for CKM syndrome because several of its defining conditions often develop silently.
A person may have:
- High blood pressure without knowing it
- Prediabetes without noticing any change
- Early CKD without symptoms
- Significant cardiovascular risk without chest pain
- Subclinical cardiovascular abnormalities detectable only through appropriate assessment
That combination explains why the 2026 CKM framework emphasizes staging, risk prediction, and screening, not simply symptom recognition.
Symptoms become increasingly important when they suggest established cardiovascular disease, advanced kidney dysfunction, or an acute emergency. But by then, the underlying process may have been developing for years.
The more useful strategy is to know relevant risk factors and health measurements before symptoms appear.
The Main Takeaway: Feeling Well Does Not Always Mean Low CKM Risk
The absence of symptoms can be reassuring in many circumstances, but it cannot rule out CKM syndrome.
Prediabetes, hypertension, and early chronic kidney disease are frequently silent. Stage 3 specifically recognizes that cardiovascular or kidney damage and very high cardiovascular risk can exist before obvious clinical cardiovascular disease appears.
As CKM-related conditions progress, symptoms such as shortness of breath, swelling, palpitations, fatigue, leg discomfort, or changes associated with advanced kidney disease may occur. These symptoms deserve evaluation, but they are not specific enough to diagnose CKM syndrome on their own.
For most people, the most effective way to identify CKM risk early is therefore not to wait for a warning sensation. It is to understand personal risk factors and have appropriate blood pressure, metabolic, kidney, and cardiovascular assessment based on individual health circumstances.
This article provides general educational information and does not diagnose CKM syndrome or the cause of individual symptoms. New, persistent, or worsening symptoms should be evaluated by a qualified healthcare professional. Suspected heart attack, stroke, or another medical emergency requires immediate emergency care.
References
- Ndumele CE, Rodriguez F, Dixon DL, et al. “2026 AHA/ACC/ADA/ASN Guideline for the Prevention, Detection, Evaluation, and Management of Cardiovascular-Kidney-Metabolic Syndrome.” Circulation and Journal of the American College of Cardiology, 2026.
- American Heart Association. “Understanding Staging for Cardiovascular-Kidney-Metabolic Syndrome (CKM Syndrome).” 2026.
- American Heart Association. “2026 Cardiovascular-Kidney-Metabolic Syndrome Guideline: Patient Toolkit.” 2026.
- National Institute of Diabetes and Digestive and Kidney Diseases. “What Is Chronic Kidney Disease in Adults?” National Institutes of Health.
- American Heart Association. “Warning Signs of a Heart Attack” and “Heart Failure Signs and Symptoms.” Reviewed 2024–2025.
- Centers for Disease Control and Prevention. “Prediabetes—Your Chance to Prevent Type 2 Diabetes” and “Diabetes Testing.” 2024.